Brief Activities for Schizophrenia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how short online activities, known as "Brief Activities," impact mood and attitudes in people with schizophrenia. The study includes two types of activities: one focuses on managing emotions, and the other on changing beliefs. It seeks participants diagnosed with a psychotic disorder, such as schizophrenia, or those without any current mental health diagnosis. Participants will engage in these activities to determine if they improve daily mood and thoughts. As an unphased trial, this study provides a unique opportunity to contribute to understanding how brief interventions can enhance mental well-being.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these brief activities are safe for participants?
Research shows that the activities tested in this study, "Emotion Coping Activities" and "Belief Modifying Activities," help people with schizophrenia manage their emotions and beliefs. "Emotion Coping Activities" include techniques like seeking social support or meditation, which previous studies have found helpful and generally well-received by participants.
"Belief Modifying Activities" assist people with schizophrenia in adjusting their beliefs, particularly to manage symptoms like paranoia. Research indicates that these techniques are safe and aim to improve mental health without causing harm.
In summary, both types of activities have been studied before and are considered safe ways to help people with schizophrenia manage their symptoms effectively.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer innovative approaches to managing schizophrenia symptoms. Unlike standard medications that often focus on chemical imbalances, Emotion Coping Activities and Belief Modifying Activities aim to address the psychological and emotional challenges associated with schizophrenia. These brief, activity-based interventions could potentially provide faster, non-pharmacological symptom relief and empower patients by enhancing their coping strategies and modifying distressing beliefs. This could lead to more personalized and holistic care, offering new hope for those who may not respond well to traditional treatments.
What evidence suggests that this trial's treatments could be effective for schizophrenia?
This trial will compare two types of brief activities for schizophrenia. Research has shown that Emotion Coping Activities, one of the treatment arms, can enhance life for people with schizophrenia by helping them understand and manage their feelings better, resulting in improved social interactions and reduced stress. Studies have found these techniques helpful in addressing the ongoing stress associated with schizophrenia.
Conversely, Belief Modifying Activities, another treatment arm, focus on altering core beliefs and thought patterns. Research suggests that changing these beliefs can help manage symptoms and improve mental health. These activities aim to stabilize beliefs, leading to better social interactions and overall well-being for those with schizophrenia.12367Are You a Good Fit for This Trial?
This trial is for adults aged 18-65. It includes two groups: one with individuals diagnosed with a psychotic disorder (like schizophrenia), and another group of healthy controls without any current DSM-5 diagnosis as confirmed by the SCID.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in brief online activities designed to influence mood and attitudes
Follow-up
Participants are monitored for changes in mood and attitudes after completing the online activities
What Are the Treatments Tested in This Trial?
Interventions
- Brief Activities
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor